Overview

Impact of Nesiritide Infusion for Decompensated Heart Failure in the Emergency Department

Status:
Completed
Trial end date:
2005-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if an 8hr infusion of nesiritide in the emergency department in the Acutely decompensated heart failure patients will decrease 30 day recidivism.
Phase:
Phase 4
Details
Lead Sponsor:
University of Texas Southwestern Medical Center
Collaborator:
Scios, Inc.
Treatments:
Natriuretic Peptide, Brain
Pharmaceutical Solutions